BRAF and thyroid cancer: Furthermore, it was reported that in thyroid cancer cells (harbouring BRAFV600E mutation) BAG3 can regulate cell growth both in vitro and in vivo and the underlying molecular mechanism appears to rely on BAG3 binding to BRAF, that protects BRAF from proteasome-dependent degradation [18].